Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · APOLLOHOSP

APOLLO HOSP.

HealthcareHealthcare Services₹116106 cr market cap
₹8729.50 ▼ -1.04% today As of 19 Nov 2026
52-week low ₹6793.5052-week high ₹9069.00

-2.7% from the 52-week high · +29.8% above the low

Apollo Hospitals Enterprise Ltd. engages in the operation and management of hospitals, diagnostic centers and pharmacies. The company is headquartered in Chennai, Tamil Nadu and currently employs 83,147 full-time employees. The firm is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. The firm's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The company is engaged in hospitals and hospitals-based services. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast moving consumer goods and private label products business from various services using the digital platform. The firm has approximately 10,000 beds across 71 hospitals, 6000 pharmacies and 200 clinics and diagnostic centers, as well as 150 telemedicine centers.

The short version. APOLLO HOSP. reported revenue of ₹7,615 crore for Sep 2026, up 20.8% from a year earlier. Net profit was ₹630 crore (up 32.1% year on year). Return on equity was 20.5% in Mar 2026. Promoter holding was 28.02% in Sep 2026, down 1.31 points over 8 quarters.

1 · The price

How has the stock traded?

APOLLO HOSP. trades 2.7% below its 52-week high and 29.8% above its 52-week low.

Change over period: —

1M+14.6%
3M+0.8%
6M+9.2%
1Y+19.4%

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue76157044660664776304584255925527
Net profit630581529502477433390372
Net margin %8.38.28.07.87.67.47.06.7
EPS (₹)43.8140.3936.8134.9333.1930.127.125.89

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue252282179419059166121466310560112479617
Net profit194214468998191056150455236
Net margin %7.76.64.74.97.21.44.02.5
EPS (₹)135.04100.5662.556.9773.4210.4632.716.97

3 · The quality

How well does it turn capital into profit?

Return on equity was 20.5% in Mar 2026; debt to equity is 0.60.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %20.517.613.013.2
Return on capital %19.515.315.013.7
EBITDA margin %15.514.613.012.8
Net margin %7.66.64.74.9

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR15.0%19.1%
Profit CAGR33.3%66.8%
Debt to equity0.60
Interest cover6.8x
Current ratio1.06

4 · The owners

Who holds it, and are they adding?

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter29.3329.3429.3428.0228.0228.0228.0228.02-1.31
FII45.2742.7443.4944.243.5442.6241.543.18-2.09
DII19.9822.2921.3421.1221.5122.7623.7222.07+2.09
Public5.195.415.616.436.716.376.546.49+1.3

Mutual fund holdings · Oct 2026

406 schemes hold this stock

337 the month before.

  • Groww BSE Hospitals ETF21.36% of NAV
  • Invesco India Pharma and Healthcare Fund9.08% of NAV
  • SBI Equity Minimum Variance Fund8.13% of NAV
  • Invesco India Business Cycle Fund7.93% of NAV
  • DSP Healthcare Fund7.89% of NAV
  • Bandhan Healthcare Fund7.67% of NAV
  • ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETF7.54% of NAV
  • DSP Nifty Healthcare Index Fund7.54% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for APOLLO HOSP. are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Corporate actions

Recent dividends, bonuses and splits

  • 16 Feb 2026 · Interim Dividend - Rs. 10
  • 19 Aug 2025 · Final Dividend - Rs. 10
  • 14 Feb 2025 · Interim Dividend - Rs. 9
  • 16 Aug 2024 · Final Dividend - Rs. 10
  • 20 Feb 2024 · Interim Dividend - Rs. 6
  • 18 Aug 2023 · Final Dividend - Rs. 9

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.